Dental bone graft substitutes market seen hitting $1.32B by 2031
Mordor Intelligence says the global dental bone graft substitutes market will grow from $0.93 billion in 2026 to $1.32 billion by 2031, led by North America and supported by demand for implants, periodontal care and synthetic grafts. The forecast points to faster growth in Asia-Pacific as digital dentistry and 3D-printed, customized grafts gain traction.
Why it matters: - Demand for dental bone graft substitutes is rising as periodontal disease, tooth loss and edentulism increase the need for bone regeneration before implant procedures. - Synthetic grafts are gaining share because dental clinics and manufacturers are looking for alternatives that reduce reliance on human or animal tissue sources. - The shift affects product development across hospitals, dental clinics and implant centers.
What happened: - Mordor Intelligence estimates the dental bone graft substitutes market at $0.93 billion in 2026. - The market is projected to reach $1.32 billion by 2031. - The forecast implies a 7.25% compound annual growth rate from 2026 through 2031. - North America remains the largest regional market, with 35.4% of global revenue in 2025. - Mordor Intelligence also released the report in multiple languages, including Japanese, French, German, Spanish and Portuguese.
The details: - Periodontal disease can deteriorate alveolar bone, weakening the foundation needed for dental implants and related procedures. - An aging population is adding to demand because age-related tooth loss and edentulism increase the need for bone preservation and reconstruction. - Bone graft substitutes are used in socket preservation, ridge augmentation, sinus lifts and periodontal defect regeneration. - Synthetic and alloplastic materials are gaining attention as alternatives to donor-derived grafts. - Material development is expanding around hydroxyapatite, beta-tricalcium phosphate, bioactive glass and polymer-based composites. - Growth-factor-enhanced matrices are also attracting interest for their potential to support biological activity and bone formation. - Mordor Intelligence says synthetic/alloplast materials are projected to grow at a 9.78% CAGR through 2031. - CAD/CAM workflows and 3D printing are enabling patient-specific scaffolds and surgical components for complex bone defects. - The market is segmented by product type, mechanism, material, application, end user and geography. - Product types include autograft, allograft, xenograft, synthetic/alloplast and other types. - Mechanisms include osteoconduction, osteoinduction, osteogenesis and osteopromotion. - Materials include ceramic-based, collagen-based, growth-factor-enhanced and polymer and composite. - Applications include socket preservation, ridge augmentation, sinus lift, periodontal defect regeneration and implant bone regeneration. - End users include hospitals, dental clinics and implant centers, ambulatory surgical centers, and academic and research institutes.
Between the lines: - The market outlook favors synthetic products because ethical concerns, donor-tissue availability and supply-chain requirements are pushing clinicians and buyers toward non-biologic options. - Competition is shifting toward materials with stronger clinical evidence, easier handling and clearer regulatory paths. - FDA clearances for new synthetic products in 2026 suggest the US market is still opening to more maxillofacial graft alternatives. - The category remains moderately fragmented, with implant companies, biomaterials firms and regenerative technology providers all competing.
What's next: - Asia-Pacific is projected to be the fastest-growing region, with a 11.05% CAGR from 2026 through 2031. - Growth in Asia-Pacific is linked to dental tourism, higher disposable incomes, more implant procedures and an expanding elderly population. - Thailand, China, India, Japan and South Korea are expected to create more opportunities for graft makers. - Affordability and limited reimbursement will remain barriers in several emerging markets. - The Middle East and Africa and South America are expected to offer additional growth as dental infrastructure improves. - More product launches and regulatory clearances are likely as manufacturers target synthetic alternatives and customized graft solutions.
The bottom line: - Dental bone graft substitutes are moving from a niche regenerative category to a broader growth market, with synthetic materials and digital customization shaping the next phase of competition.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
International Tech Times
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.